Oncology Trial PI LLM Adoption Guide

Repository based LLMs enable the creation of large scale documents more efficiently due to increased file generation capabilities, less errors, and a greater capacity to process an author’s prompt containing specific instructions. This process allows for adequate incorporation of source information and iterative refinements of document drafts; while using a lower number of prompts. Repository level LLMs excel in understanding document context when a finite number of appropriately sized, high quality inputs are uploaded to the author’s repository. Files generated in sections are advantageous for enabling direct access in future project builds. Single prompt multi-project outputs with a sub-prompt topics schedule informs LLM generation and execution of sub-prompts possible for creating machine readable diagrams and three sets of self learning and iteratively refined clinical trial paper files. Both clinical trial site and sponsor simulations can also be conducted at scale to observe patient, robotic, and AI interactions. LLM proficiency is possible for at least glioblastoma, pancreatic ductal adenocarcinoma, and lung adenocarcinoma. This practical guide builds from the HHS June 22, 2026 initiative to restore American leadership in clinical trials.